UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children and adults 65 years of age and older

International journal of infectious diseases, 2019-08, Vol.85, p.S10-S17

2019

Volltextzugriff (PDF)

Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children

International journal of infectious diseases, 2019-08, Vol.85, p.S26-S38

2019

Volltextzugriff (PDF)

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials

Nature communications, 2024-05, Vol.15 (1), p.4081-13, Article 4081

2024

Volltextzugriff (PDF)

Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study

Human vaccines & immunotherapeutics, 2016-09, Vol.12 (9), p.2278-2288

2016

Volltextzugriff (PDF)

A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine

npj vaccines, 2022-12, Vol.7 (1), p.161-161, Article 161

2022

Volltextzugriff (PDF)

Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial

International journal of infectious diseases, 2015-12, Vol.41 (C), p.65-72

2015

Volltextzugriff (PDF)

Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine

npj vaccines, 2022-11, Vol.7 (1), p.154-154, Article 154

2022

Volltextzugriff (PDF)

Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59® adjuvant: Results from a dose-finding clinical trial in older adults

Human vaccines & immunotherapeutics, 2012-02, Vol.8 (2), p.216-227

2012

Volltextzugriff (PDF)

Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age

Human vaccines, 2011-01, Vol.7 (1), p.58-66

2011

Volltextzugriff (PDF)

MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database

Vaccine, 2009-11, Vol.27 (49), p.6959-6965

2009

Volltextzugriff (PDF)

Deciphering immune responses: a comparative analysis of influenza vaccination platforms

Drug discovery today, 2024-09, Vol.29 (9), p.104125, Article 104125

2024

Volltextzugriff (PDF)

Responses to 2009 H1N1 Vaccine in Children 3 to 17 Years of Age

The New England journal of medicine, 2010-01, Vol.362 (4), p.370-372

2010

Volltextzugriff (PDF)

Trivalent and quadrivalent MF59® -adjuvanted influenza vaccine in young children: A dose- and schedule-finding study

Vaccine, 2011-11, Vol.29 (47), p.8696-8704

2011

Volltextzugriff (PDF)

BACTEREMIA AND BACTERIURIA AFTER TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY

The Journal of urology, 2000-07, Vol.164 (1), p.76-80

2000

Volltextzugriff (PDF)

Effect of contrast material on transitional cell carcinoma viability

Urology (Ridgewood, N.J.), 2000-11, Vol.56 (5), p.876-879

2000

Volltextzugriff (PDF)

A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration

Human vaccines & immunotherapeutics, 2014-06, Vol.10 (6), p.1701-1710

2014

Volltextzugriff (PDF)

Trivalent and quadrivalent MF59 super(&; reg; -adjuvanted influenza vaccine in young children: A dose- and schedule-finding study)

Vaccine, 2011-11, Vol.29 (47), p.8696-8704

2011

Volltextzugriff (PDF)

EFFICACY AND SAFETY OF OXYBUTYNIN IN CHILDREN WITH DETRUSOR HYPERREFLEXIA SECONDARY TO NEUROGENIC BLADDER DYSFUNCTION

The Journal of urology, 2005, Vol.173 (1), p.221-225

2005

Volltextzugriff (PDF)

882: Relationship of Self-Diagnosed Premature Ejaculation to Other Indicators of Male Sexual Function

The Journal of urology, 2004-04, Vol.171 (4), p.233-234

2004

Volltextzugriff (PDF)

883: The Utility of “Estimated Intra-Vaginal Ejaculatory Latency Time” and “DSM-IV Criteria” in Identifying Premature Ejaculation

The Journal of urology, 2004-04, Vol.171 (4), p.234-234

2004

Volltextzugriff (PDF)

EFFICACY AND SAFETY OF OXYBUTYNIN IN CHILDREN WITH DETRUSOR HYPERREFLEXIA SECONDARY TO NEUROGENIC BLADDER DYSFUNCTION

The Journal of urology, 2005-01, Vol.173 (1), p.221-225

2005

Volltextzugriff (PDF)

BACTEREMIA AND BACTERIURIA AFTER TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY

The Journal of urology, 2000-07, p.76-80

2000

Volltextzugriff (PDF)

EVALUATION AND MANAGEMENT OF PEDIATRIC URINARY TRACT INFECTIONS

Urologic clinics of North America, 1999-11, Vol.26 (4), p.719-728

1999

Volltextzugriff (PDF)

Carolina rinse solution--a new strategy to increase survival time after orthotopic liver transplantation in the rat

Transplantation, 1991-09, Vol.52 (3), p.417-423

1991

Volltextzugriff (PDF)

Evidence that adenosine is a key component in Carolina rinse responsible for reducing graft failure after orthotopic liver transplantation in the rat

Transplantation, 1991-12, Vol.52 (6), p.992-998

1991

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(22)
Humans
(13)
Female
(12)
Immunology
(10)
Male
(10)
Biological And Medical Sciences
(9)
Influenza
(7)
Influenza Vaccines - Immunology
(7)
Medical Sciences
(7)
Vaccine
(7)
Adolescent
(6)
Aged
(6)
Influenza Vaccines - Administration & Dosage
(6)
Influenza Vaccines - Adverse Effects
(6)
Influenza, Human - Prevention & Control
(6)
Vaccines
(6)
Adjuvant
(5)
Antibodies, Viral - Blood
(5)
Child
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children and adults 65 years of age and older

Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials

Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study

A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine

Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial

Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine

Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59® adjuvant: Results from a dose-finding clinical trial in older adults

Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age

MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database

Deciphering immune responses: a comparative analysis of influenza vaccination platforms

Responses to 2009 H1N1 Vaccine in Children 3 to 17 Years of Age

Trivalent and quadrivalent MF59® -adjuvanted influenza vaccine in young children: A dose- and schedule-finding study

BACTEREMIA AND BACTERIURIA AFTER TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY

Effect of contrast material on transitional cell carcinoma viability

A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration

Trivalent and quadrivalent MF59 super(&; reg; -adjuvanted influenza vaccine in young children: A dose- and schedule-finding study)

EFFICACY AND SAFETY OF OXYBUTYNIN IN CHILDREN WITH DETRUSOR HYPERREFLEXIA SECONDARY TO NEUROGENIC BLADDER DYSFUNCTION

882: Relationship of Self-Diagnosed Premature Ejaculation to Other Indicators of Male Sexual Function

883: The Utility of “Estimated Intra-Vaginal Ejaculatory Latency Time” and “DSM-IV Criteria” in Identifying Premature Ejaculation

EFFICACY AND SAFETY OF OXYBUTYNIN IN CHILDREN WITH DETRUSOR HYPERREFLEXIA SECONDARY TO NEUROGENIC BLADDER DYSFUNCTION

BACTEREMIA AND BACTERIURIA AFTER TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY

EVALUATION AND MANAGEMENT OF PEDIATRIC URINARY TRACT INFECTIONS

Carolina rinse solution--a new strategy to increase survival time after orthotopic liver transplantation in the rat

Evidence that adenosine is a key component in Carolina rinse responsible for reducing graft failure after orthotopic liver transplantation in the rat

Suchergebnisse filtern